Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma
Open Access
- 30 July 2013
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (33) , 13481-13486
Abstract
Synonymous mutations, which do not alter the protein sequence, have been shown to affect protein function [Sauna ZE, Kimchi-Sarfaty C (2011) Nat Rev Genet 12(10):683–691]. However, synonymous mutations are rarely investigated in the cancer genomics field. We used whole-genome and -exome sequencing to identify somatic mutations in 29 melanoma samples. Validation of one synonymous somatic mutation in BCL2L12 in 285 samples identified 12 cases that harbored the recurrent F17F mutation. This mutation led to increased BCL2L12 mRNA and protein levels because of differential targeting of WT and mutant BCL2L12 by hsa-miR-671–5p. Protein made from mutant BCL2L12 transcript bound p53, inhibited UV-induced apoptosis more efficiently than WT BCL2L12 , and reduced endogenous p53 target gene transcription. This report shows selection of a recurrent somatic synonymous mutation in cancer. Our data indicate that silent alterations have a role to play in human cancer, emphasizing the importance of their investigation in future cancer genome studies.Keywords
This publication has 35 references indexed in Scilit:
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanomaNature Genetics, 2012
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencingNature Genetics, 2011
- Evolution of adaptive phenotypic traits without positive Darwinian selectionHeredity, 2011
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanomaNature Genetics, 2009
- The role of site accessibility in microRNA target recognitionNature Genetics, 2007
- Patterns of somatic mutation in human cancer genomesNature, 2007
- Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapyNature Clinical Practice Oncology, 2006
- Mutations of the BRAF gene in human cancerNature, 2002